| Immuno-genomic landscape of osteosarcoma CC Wu, HC Beird, J Andrew Livingston, S Advani, A Mitra, S Cao, ... Nature communications 11 (1), 1008, 2020 | 184 | 2020 |
| Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial N Somaiah, AP Conley, ER Parra, H Lin, B Amini, LS Soto, R Salazar, ... The Lancet Oncology 23 (9), 1156-1166, 2022 | 77 | 2022 |
| Spatially resolved analyses link genomic and immune diversity and reveal unfavorable neutrophil activation in melanoma A Mitra, MC Andrews, W Roh, MP De Macedo, CW Hudgens, F Carapeto, ... Nature communications 11 (1), 1-18, 2020 | 23 | 2020 |
| B‐cell lymphoma/leukaemia 11B (BCL11B) expression status helps distinguish early T‐cell precursor acute lymphoblastic leukaemia/lymphoma (ETP‐ALL/LBL) from other subtypes of T … H Fang, W Wang, S El Hussein, K Morita, HC Beird, A Mitra, S Loghavi, ... British Journal of Haematology 194 (6), 1034-1038, 2021 | 10 | 2021 |
| GPS-Based spatial and spectral registration of delta-heading multipass SAR imagery for coherent change detection R Dilsavor, A Mitra, M Hensel, M Soumekh US Army Workshop on Synthetic Aperture Radar Technology, 2002 | 10 | 2002 |
| Immuno-genomic landscape of osteosarcoma. Nat Commun. 2020; 11: 1008 CC Wu, HC Beird, J Andrew Livingston, S Advani, A Mitra, S Cao, ... Interesting manuscript identifying potential immunotherapeutic targets in …, 0 | 5 | |
| Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma R Chen, J Li, J Fujimoto, L Hong, X Hu, K Quek, M Tang, A Mitra, ... Journal of Experimental & Clinical Cancer Research 41 (1), 172, 2022 | 2 | 2022 |
| Evaluation of pinhole technique for castration in dogs AA Jadhav, MG Thorat, RV Raulkar, KN Tayade, AA Mitra, MB Pawar Indian Journal of Veterinary Surgery 43 (1), 43-45, 2022 | 1 | 2022 |
| Multi-spatial whole-lesion molecular heterogeneity of an immunotherapy-resistant metastatic melanoma. A Mitra, W Roh, A Reuben, M Macedo, FCL Carapeto, C Gumbs, J Zhang, ... Journal of Clinical Oncology 36 (15_suppl), 9568-9568, 2018 | 1 | 2018 |
| Dynamic Changes in Circulating Tumor Fraction as a Predictor of Real-World Clinical Outcomes in Solid Tumor Malignancy Patients Treated with Immunotherapy RD Gentzler, J Guittar, A Mitra, WT Iams, T Driessen, R Schwind, ... Oncology and Therapy, 1-16, 2024 | | 2024 |
| Cost-effectiveness of a circulating tumor fraction molecular biomarker for treatment response monitoring. Z Rivers, C Aggarwal, MR Matrana, JL Feliciano, A Mitra, H Nimeiri, ... Journal of Clinical Oncology 42 (16_suppl), 11082-11082, 2024 | | 2024 |
| Relationship between dynamic changes in circulating tumor fraction and real-world imaging with real-world survival in patients with solid tumors treated with immunotherapy. WT Iams, A Mitra, J Guittar, RD Gentzler, RM Schwind, AJ Dugan, Y Liu, ... Journal of Clinical Oncology 42 (16_suppl), 3046-3046, 2024 | | 2024 |
| Association of a ctDNA biomarker of treatment response with clinical outcomes in a real-world pan-cancer cohort treated with tyrosine kinase inhibitors A Mitra, J Guittar, R Schwind, T Driessen, M Berginski, C Lo, MM Stein, ... Cancer Research 84 (6_Supplement), 5145-5145, 2024 | | 2024 |
| Distribution and Prognostic Significance of T Cell Phenotypes in the Immune Microenvironment of Esophageal Adenocarcinoma and Barrett Esophagus I Khanduri, R Pandurengan, AM Correa, R Katkhuda, A Verma, A Mejia, ... Preprints, 2023 | | 2023 |
| 34 Association of a novel circulating tumor fraction DNA biomarker of treatment response monitoring and clinical outcomes in a real-world, diverse pan-cancer cohort treated … J Guittar, R Gentzler, A Mitra, MM Stein, C Lo, W Zhu, T Driessen, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 203P Genomic characterization of sporadic MET amplified non-small cell lung cancer (NSCLC) and association with real-world outcomes RD Gentzler, N Sharma, A Mitra, R Ben-Shachar, M Stein, J Guinney, ... Annals of Oncology 34, S263, 2023 | | 2023 |
| Homologous recombination deficiency (HRD) in non-small cell lung cancer: Genomic analysis using an RNA-based HRD algorithm. S Thiede, M Berginski, A Mitra, TJ Taxter, MM Stein, R Ben-Shachar, ... Journal of Clinical Oncology 41 (16_suppl), 3123-3123, 2023 | | 2023 |
| Distribution and Significance of T cell Phenotypes in Immune Microenvironment of Esophageal Adenocarcinoma and Barrett's Esophagus I Khanduri, A Correa, R Krishnaramanujam, R Katkhuda, A Verma, ... LABORATORY INVESTIGATION 102 (SUPPL 1), 478-480, 2022 | | 2022 |
| Immunogenomic correlates of response to combination immune checkpoint blockade in advanced sarcoma A Mitra, N Somaiah, AP Conley, B Amini, H Lin, BE Sanchez, ... Cancer Research 81 (13_Supplement), 518-518, 2021 | | 2021 |
| Clinical Evaluation of Multimodal Analgesia for Optimum Post-Operative Pain Management in Dog Undergoing Ovariohysterectomy AA Mitra, MG Thorat, RV Raulkar, KN Tayade, AA Jadhav, KS Pawar, ... MAFSU, Nagpur, 2021 | | 2021 |
